These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17373938)
21. Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction. Hanasaki H; Takemura Y; Fukuo K; Ohishi M; Onishi M; Yasuda O; Katsuya T; Awata N; Kato N; Ogihara T; Rakugi H Hypertens Res; 2009 Apr; 32(4):261-4. PubMed ID: 19262492 [TBL] [Abstract][Full Text] [Related]
22. Novel polymorphism of the 5-lipoxygenase activating protein (FLAP) promoter gene associated with asthma. Koshino T; Takano S; Kitani S; Ohshima N; Sano Y; Takaishi T; Hirai K; Yamamoto K; Morita Y Mol Cell Biol Res Commun; 1999 Jul; 2(1):32-5. PubMed ID: 10527888 [TBL] [Abstract][Full Text] [Related]
23. CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases. Rechciński T; Grebowska A; Kurpesa M; Peruga Z; Dziuba M; Krzemińska-Pakuła M; Rudnicka W; Chmiela M Kardiol Pol; 2007 Mar; 65(3):237-44; discussion 245. PubMed ID: 17436151 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Drazen JM; Yandava CN; Dubé L; Szczerback N; Hippensteel R; Pillari A; Israel E; Schork N; Silverman ES; Katz DA; Drajesk J Nat Genet; 1999 Jun; 22(2):168-70. PubMed ID: 10369259 [TBL] [Abstract][Full Text] [Related]
25. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Zhang P; Tchou-Wong KM; Costa M Cancer Res; 2007 Oct; 67(19):9125-33. PubMed ID: 17909017 [TBL] [Abstract][Full Text] [Related]
26. The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease. Rife T; Rasoul B; Pullen N; Mitchell D; Grathwol K; Kurth J J Neurosci Res; 2009 Aug; 87(10):2319-25. PubMed ID: 19326438 [TBL] [Abstract][Full Text] [Related]
27. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512 [TBL] [Abstract][Full Text] [Related]
28. Microsatellite in the 3' untranslated region of human fibroblast growth factor 9 (FGF9) gene exhibits pleiotropic effect on modulating FGF9 protein expression. Chen TM; Kuo PL; Hsu CH; Tsai SJ; Chen MJ; Lin CW; Sun HS Hum Mutat; 2007 Jan; 28(1):98. PubMed ID: 17154280 [TBL] [Abstract][Full Text] [Related]
29. Interactions between 5-Lipoxygenase Polymorphisms and Adipose Tissue Contents of Arachidonic and Eicosapentaenoic Acids Do Not Affect Risk of Myocardial Infarction in Middle-Aged Men and Women in a Danish Case-Cohort Study. Gammelmark A; Lundbye-Christensen S; Tjønneland A; Schmidt EB; Overvad K; Nielsen MS J Nutr; 2017 Jul; 147(7):1340-1347. PubMed ID: 28566527 [No Abstract] [Full Text] [Related]
30. The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the -129A allele in women. Zotova E; Lyrenäs L; de Faire U; Morgenstern R; Gigante B; Bennet AM Coron Artery Dis; 2009 Aug; 20(5):322-6. PubMed ID: 19543083 [TBL] [Abstract][Full Text] [Related]
31. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers. Tsuge M; Hamamoto R; Silva FP; Ohnishi Y; Chayama K; Kamatani N; Furukawa Y; Nakamura Y Nat Genet; 2005 Oct; 37(10):1104-7. PubMed ID: 16155568 [TBL] [Abstract][Full Text] [Related]
32. ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma. Mougey E; Lang JE; Allayee H; Teague WG; Dozor AJ; Wise RA; Lima JJ Clin Exp Allergy; 2013 May; 43(5):512-20. PubMed ID: 23600541 [TBL] [Abstract][Full Text] [Related]
33. Protective role of 27bp repeat polymorphism in intron 4 of eNOS gene in lacunar infarction. Yemişçi M; Sinici I; Ozkara HA; Hayran M; Ay H; Celtikçi B; Onder E; Büyükşerbetci G; Kaya EB; Tokgözoglu L; Dalkara T Free Radic Res; 2009 Mar; 43(3):272-9. PubMed ID: 19184759 [TBL] [Abstract][Full Text] [Related]
34. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. Manna I; Labate A; Gambardella A; Forabosco P; La Russa A; Le Piane E; Aguglia U; Quattrone A Neurosci Lett; 2007 Jun; 421(1):52-6. PubMed ID: 17548158 [TBL] [Abstract][Full Text] [Related]
35. Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1. Gannon AM; Turner EC; Reid HM; Kinsella BT J Mol Biol; 2009 Nov; 394(1):29-45. PubMed ID: 19747485 [TBL] [Abstract][Full Text] [Related]
37. SP1 regulates a human SNAP-25 gene expression. Cai F; Chen B; Zhou W; Zis O; Liu S; Holt RA; Honer WG; Song W J Neurochem; 2008 Apr; 105(2):512-23. PubMed ID: 18194215 [TBL] [Abstract][Full Text] [Related]
38. [Study on the association of -689C/T polymorphism in the PPARgamma2 promoter with myocardial infarction]. Li JP; Cheng LX; He MA; Wu TC Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):19-22. PubMed ID: 18247297 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the human SLC22A18 gene promoter and its regulation by the transcription factor Sp1. Ali AM; Bajaj V; Gopinath KS; Kumar A Gene; 2009 Jan; 429(1-2):37-43. PubMed ID: 18996451 [TBL] [Abstract][Full Text] [Related]
40. [Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder]. Kereszturi E; Király O; Csapó Z; Tárnok Z; Gádoros J; Sasvári-Székely M; Nemoda Z Neuropsychopharmacol Hung; 2007 Mar; 9(1):11-8. PubMed ID: 17879560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]